34 related articles for article (PubMed ID: 10803525)
1. Anaplastic plasmacytomas: relationships to normal memory B cells and plasma cell neoplasms of immunodeficient and autoimmune mice.
Qi CF; Shin DM; Li Z; Wang H; Feng J; Hartley JW; Fredrickson TN; Kovalchuk AL; Morse HC
J Pathol; 2010 May; 221(1):106-16. PubMed ID: 20217872
[TBL] [Abstract][Full Text] [Related]
2. MYC inhibitors in multiple myeloma.
Martínez-Martín S; Soucek L
Cancer Drug Resist; 2021; 4(4):842-865. PubMed ID: 35582389
[TBL] [Abstract][Full Text] [Related]
3. 3'
Kovalchuk AL; Sakai T; Qi CF; Du Bois W; Dunnick WA; Cogné M; Morse HC
Oncotarget; 2018 Oct; 9(77):34528-34542. PubMed ID: 30349647
[No Abstract] [Full Text] [Related]
4. Genetic reporter system for oncogenic Igh-Myc translocations in mice.
Takizawa M; Kim JS; Tessarollo L; McNeil N; Waldschmidt TJ; Casellas R; Ried T; Janz S
Oncogene; 2010 Jul; 29(28):4113-20. PubMed ID: 20453890
[TBL] [Abstract][Full Text] [Related]
5. IL-6 and MYC collaborate in plasma cell tumor formation in mice.
Rutsch S; Neppalli VT; Shin DM; DuBois W; Morse HC; Goldschmidt H; Janz S
Blood; 2010 Mar; 115(9):1746-54. PubMed ID: 20018915
[TBL] [Abstract][Full Text] [Related]
6. AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements.
Kovalchuk AL; duBois W; Mushinski E; McNeil NE; Hirt C; Qi CF; Li Z; Janz S; Honjo T; Muramatsu M; Ried T; Behrens T; Potter M
J Exp Med; 2007 Nov; 204(12):2989-3001. PubMed ID: 17998390
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.
Cheung WC; Kim JS; Linden M; Peng L; Van Ness B; Polakiewicz RD; Janz S
J Clin Invest; 2004 Jun; 113(12):1763-73. PubMed ID: 15199411
[TBL] [Abstract][Full Text] [Related]
8. IL-6 transgenic mouse model for extraosseous plasmacytoma.
Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
[TBL] [Abstract][Full Text] [Related]
9. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
[TBL] [Abstract][Full Text] [Related]
10. Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in mice.
Kovalchuk AL; Janz S
Int J Cancer; 2002 Oct; 101(5):423-6. PubMed ID: 12216069
[TBL] [Abstract][Full Text] [Related]
11. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
Potter M; Wiener F
Carcinogenesis; 1992 Oct; 13(10):1681-97. PubMed ID: 1423827
[TBL] [Abstract][Full Text] [Related]
13. Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations.
Kovalchuk AL; Mushinski EB; Janz S
Leukemia; 2000 May; 14(5):909-21. PubMed ID: 10803525
[TBL] [Abstract][Full Text] [Related]
14. Genetic recombinations between c-myc and Igh mu as precursors for recombinations between c-myc and Igh alpha in BALB/c plasmacytomas.
Janz S; Kovalchuk AL; Müller JR; Potter M
Curr Top Microbiol Immunol; 1997; 224():241-50. PubMed ID: 9308247
[TBL] [Abstract][Full Text] [Related]
15. Deletional remodeling of c-myc-deregulating chromosomal translocations.
Kovalchuk AL; Müller JR; Janz S
Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
